TY - CONF A1 - Blaeß, Carsten A1 - Reinsch, Stefan A1 - Müller, Ralf A1 - Brauer, D. S. T1 - Sintering and crystallization of new bioactive glasses N2 - Bioglass® 45S5 is mainly used clinically as powders, granules or pastes instead of sintered compacts. This is due to the inherent problem of crystallization during sintering. Recently, new bioactive glasses with improved crys-tallization stability have been developed as promising candidates for manufacturing of sintered powder compacts for bone regeneration, which combine improved sintering behavior with bioactivity. Compared with the well-known Bioglass® 45S5 (SiO2-P2O5-CaO-Na2O) the calcium/alkali oxide ratio was increased, sodium oxide was partially replaced by potassium oxide and up to 3 mol% calcium fluoride were added, in order to stabilize the glass against crystallization. Sintering and crystallization were characterized by heating microscopy, XRD, FTIR, SEM, and DTA. The results show that a sintered density of 88-99 % is achieved in contrast to only 57-67% for Bioglass® 45S5. Whereas Bioglass® 45S5 powder compacts crystallize during sintering, for the new glasses no crystalline phases were detected. Additionally the influence of grain size was characterized. These studies showed that full densification can be attained for particle size < 32 µm, whereas coarser particles pro-gressively increase residual porosity. Observed foaming phenomena, are strongly retarded by crystallization. T2 - 90. Glastechnische Tagung (Deutsche Glastechnische Gesellschaft e.V.) CY - Goslar, Germany DA - 06.06.2016 KW - Bioactive KW - Glass KW - Crystallization KW - Sintering PY - 2016 AN - OPUS4-38311 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -